PMID: 8968451Dec 1, 1996Paper

Potential interaction between warfarin and fluvastatin

The Annals of Pharmacotherapy
L E TrilliB A Kroner

Abstract

To report three cases of a suspected interaction between warfarin and fluvastatin. Three patients receiving stable warfarin dosages with therapeutic international normalized ratios (INRs) exhibited increased INRs when fluvastatin was added to their maintenance regimens. While none of the patients experienced a bleeding episode, they did require a reduction in their weekly warfarin dosage to achieve an appropriate level of anticoagulation. Reports of an interaction between warfarin and lovastatin have been described previously; however, to our knowledge, this is the first published report of a possible interaction between warfarin and fluvastatin. These cases were chosen because other factors that could potentially increase the INR were ruled out as significant contributors. The exact mechanism for the potential interaction between warfarin and fluvastatin is unknown. Until more is known, it is advisable to monitor patients more frequently when fluvastatin is initiated, discontinued, or adjusted in patients taking warfarin.

Citations

May 31, 2002·Clinical Pharmacokinetics·David Williams, John Feely
Sep 8, 2005·Expert Opinion on Pharmacotherapy·Mark Y Chan, Chi Hang Lee
Jun 15, 2007·The Annals of Pharmacotherapy·Tone WestergrenEspen Molden
Oct 5, 2001·Expert Opinion on Pharmacotherapy·C R Worz, M Bottorff
Sep 8, 2004·Expert Review of Cardiovascular Therapy·Anders Asberg, Hallvard Holdaas
Apr 17, 2012·British Journal of Hospital Medicine·J W MackayK S Myint
Oct 25, 2013·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Anida Causevic-Ramosevac, Sabina Semiz
Feb 13, 1999·Journal of Clinical Pharmacology·J C LinD B Marcus
Sep 1, 2005·European Journal of Clinical Pharmacology·Daisy JindalK K Pillai
May 23, 2007·Clinical Drug Investigation·Pratapa P PrasadLeonard Gonasun
May 23, 2001·Clinical Pharmacokinetics·C D Scripture, J A Pieper
Nov 28, 2001·Journal of Clinical Pharmacy and Therapeutics·N J Langford, M J Kendall
Mar 23, 2001·The Annals of Pharmacotherapy·V J Colucci, J F Knapp
Oct 5, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·M H Davidson
Oct 19, 2016·Circulation·Barbara S WigginsUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; C
Nov 20, 2002·Expert Opinion on Pharmacotherapy·J M Lawrence, J P D Reckless
Jul 20, 2005·Journal of Clinical Pharmacology·Steven G SimonsonDennis W Schneck
Oct 16, 2001·Drugs & Aging·B TomlinsonW Lan
Dec 14, 2011·Current Medical Research and Opinion·Christine Y YuRoger E Morgan
Jan 28, 2010·The American Journal of Medicine·Hedi SchellemanSean Hennessy
Feb 9, 2000·Pharmacology & Therapeutics·A CorsiniF Bernini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved